Mirae Asset Global ETFs Holdings
PSTX

Mirae Asset Global ETFs Holdings’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio PSTX Stock Details PSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-141,339
Closed -$1.36M – 3112
2024
Q4 		$1.36M Sell
141,339
-10,115
-7% -$52.8K ﹤0.01% 1376
2024
Q3 		$433K Sell
151,454
-21,658
-13% -$67K ﹤0.01% 1990
2024
Q2 		$505K Buy
+173,112
New +$473K ﹤0.01% 1822

Other funds holding PSTX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's PSTX Position: Q1 2025 in Review

Mirae Asset Global ETFs Holdings sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q1 2025, closing a stake of 141,339 shares — an estimated $1.36M sold.

Mirae Asset Global ETFs Holdings first reported a position in PSTX in Q2 2024 and held it in 3 quarters. The position peaked at $1.36M in Q4 2024. 1 fund tracked by Wall St. Rank holds PSTX as of Q1 2025.

  • Mirae Asset Global ETFs Holdings reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 141,339 Poseida Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $1.36M.
  • Mirae Asset Global ETFs Holdings first reported a position in Poseida Therapeutics, Inc. Common Stock in Q2 2024 and held it in 3 quarters.
  • Mirae Asset Global ETFs Holdings's Poseida Therapeutics, Inc. Common Stock position peaked at $1.36M in Q4 2024.
  • 1 fund tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2025, filed 15 May 2025.